Volume 5, Issue 8: Using Real World Data to Individualize HCV Management
e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 5, Issue 8)
Nurses and health care professionals involved in the care of patients with Hepatitis.
After participating in this activity, the participant will demonstrate the ability to:
- Discuss the real-world data to support a sofosbuvirledipasvir treatment duration of 8 weeks versus 12 weeks.
- Summarize the current hepatitis C treatment options for patients with advanced kidney disease.
- Describe the risks and benefits of hepatitis C therapies in HIV-HCV coinfected patients.
- 0.50 ANCC
- 1.00 Attendance